Status:
COMPLETED
Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
Brief Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control, weight change and hypoglycaemic effects in patients with type 2 diabetes with Levemir® comp...
Eligibility Criteria
Inclusion
- Type 2 diabetes failing on oral blood glucose lowering therapy, and requiring insulin therapy.
Exclusion
- Type 1 diabetes
- Previous use of insulin
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
342 Patients enrolled
Trial Details
Trial ID
NCT00715351
Start Date
May 1 2007
End Date
July 1 2008
Last Update
November 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Ljubljana, Slovenia, SI-1000